Monoclonal Anti-PTX Antibody, Rabbit IgG1 (M1G12)

  • Antibody Internalization Detection Reagent (IGG-PZF2001) monitors endocytosis in live cells
ユーザーレビュー
製品番号/仕様
価格
数量
PTX-MY2607-100ug
$325.00
PTX-MY2607-1mg (500ug X 2)
$2040.00
ETA of in-stock products:2 business days
総アイテム数 製品金額$ 0

製品詳細

  • Source

    Monoclonal Anti-PTX Antibody, Rabbit IgG1 (M1G12) is a rabbit monoclonal antibody recombinantly expressed in HEK293 cells.

  • Antibody Type

    Recombinant Monoclonal

  • Clone

    M1G12

  • Isotype

    Rabbit IgG, Kappa

  • Host Species

    Rabbit

  • Immunogen

    PTX-BSA

  • Specificity

    Specifically recognizes PTX.

  • Purification

    Protein A purified / Protein G purified.

  • Concentration

    Please refer to the Certificate of Analysis (CoA).

  • Form

    Lyophilized

  • Formulation

    Lyophilized from a 0.22 μm-filtered solution in PBS (pH 7.4), with trehalose as protectant.

    Please contact us for customized product forms or formulations.

  • Reconstitution

    Please refer to the Certificate of Analysis (CoA) for specific instructions.

  • Shipping

    Lyophilized product is shipped at ambient temperature.

  • Storage

    For long term storage, the product should be stored in a lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • Notices

    Product Specific Notices: For research use only.

  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

お客様はこちらも閲覧

データ表示

  • Bioactivity-ELISA

     PTX ELISA

    Immobilized Monoclonal Anti-PTX Antibody, Rabbit IgG1 (M1G12) (Cat. No. PTX-MY2607) at 1 μg/mL, add Anti-HER2 mAb-Paclitaxel ADC in the 100% Human Serum and then add Biotinylated Human Her2, His,Avitag, premium grade (Cat. No. HE2-H82E2) at 0.5 μg/mL. Detection was performed using HRP-conjugated Streptavidin (Acro, Cat. No. STN-NH913) (QC tested).

    Protocol
  •  PTX ELISA

    Immobilized Monoclonal Anti-PTX Antibody, Rabbit IgG1 (M1G12) (Cat. No. PTX-MY2607) at 1 μg/mL, add Anti-HER2 mAb-Paclitaxel ADC in the 0.5% BSA and then add Biotinylated Human Her2, His,Avitag, premium grade (Cat. No. HE2-H82E2) at 0.5 μg/mL. Detection was performed using HRP-conjugated Streptavidin (Acro, Cat. No. STN-NH913) (Routinely tested).

    Protocol
  •  PTX ELISA

    Immobilized Monoclonal Anti-PTX Antibody, Rabbit IgG1 (M1G12) (Cat. No. PTX-MY2607) at 1 μg/mL (100 μL/well) can bind Anti-HER2 mAb-Paclitaxel ADC with a linear range of 0.5-31 ng/mL (Routinely tested).

    Protocol
  • Cross Verification

     PTX CROSS_VERIFICATION

    ELISA binding of Monoclonal Anti-PTX Antibody, Rabbit IgG1 (M1G12) (Cat. No. PTX-MY2607) with Anti-HER2 mAb-Paclitaxel ADC, Tusamitamab Ravtansine, Trastuzumab Deruxtecan, Sacituzumab Govitecam, Disitamab Vedotin (RC48), ADC-Duocarmycin, and ADC-NMTi conjugated antibody respectively.
    The coating antibody was Monoclonal Anti-PTX Antibody, Rabbit IgG1 (M1G12) (Cat. No. PTX-MY2607), used at 1 μg/mL concentration. The primary antibody were different payload conjugated antibodies, including Anti-HER2 mAb-Paclitaxel ADC, Tusamitamab Ravtansine, Trastuzumab Deruxtecan, Sacituzumab Govitecam, Disitamab Vedotin (RC48), ADC-Duocarmycin, and ADC-NMTi conjugated antibodies used at 0.5 μg/mL concentration. The secondary antibody was HRP conjugated Anti-Human-IgG-Fc Antibody (6F11C8), mAb (Acro, Cat. No. IGG-LY69) used at 1:10000 concentration.
    Monoclonal Anti-PTX Antibody, Rabbit IgG1 (M1G12) (Cat. No. PTX-MY2607) is specific to Anti-HER2 mAb-Paclitaxel ADC and has no cross-reactivity with Tusamitamab Ravtansine, Trastuzumab Deruxtecan, Sacituzumab Govitecam, Disitamab Vedotin (RC48), ADC-Duocarmycin and ADC-NMTi (Routinely tested).

ユーザーレビュー
コメントを投稿

バックグランド

Paclitaxel (PTX) is a natural diterpenoid anticancer compound extracted from Taxus brevifolia. It stabilizes microtubule structure, inhibits tubulin depolymerization and arrests cell mitosis, thus exerting broad-spectrum antitumor activity and being widely used in clinical chemotherapy.

最新の進展

 
お問い合わせ
医薬品候補ライセンス
他の関連情報
  • 製品情報
  • 製品詳細
  • お客様はこちらも閲覧
  • データ表示
  • ユーザーレビュー
  • 背景
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8